glaucomaНациональный журнал ГлаукомаNational Journal glaucoma2078-41042311-6862Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”10.53432/2078-4104-2024-23-3-54-66glaucoma-536Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSВзаимосвязь между различными формами первичной глаукомы и ретинальной венозной окклюзиейThe relationship between different types of primary glaucoma and retinal vein occlusionhttps://orcid.org/0000-0001-7311-0954ГалимоваА. Б.GalimovaA. B.

К.м.н., заведующий отделением офтальмологии 

450075, Уфа, ул. Р. Зорге, 67/1

Cand. Sci. (Med.), Head of the Department of Ophthalmology 

67/1 Rikharda Zorghe St., Ufa, 450075 

aible@mail.ruhttps://orcid.org/0000-0001-9606-0566КуроедовА. В.KuroyedovA. V.

Д.м.н., заведующий кафедрой офтальмологии, начальник офтальмологического центра 

117997, Москва, ул. Островитянова, 1 

107014, Москва, ул. Б. Оленья, 8А 

Dr. Sci. (Med.), Head of the Academic Department of Ophthalmology, Head of the Ophthalmology Center

1 Ostrovityanova St., Moscow, 117997 

8A Bolshaya Olenya St., Moscow, 107014 

https://orcid.org/0000-0002-1610-108XГалимоваВ. У.GalimovaV. U.

Д.м.н., профессор, профессор кафедры офтальмологии с курсом ИДПО

450008, Уфа, ул. Ленина, 3

Dr. Sci. (Med.), Professor, Professor at the Academic Department of Ophthalmology with PGE course

3 Lenina St., Ufa, Russian Federation, 450008

ФГБОУ ВО «БГМУ» Минздрава России (ВЦГПХ)РоссияRussian Center for Eye and Plastic Surgery of the Bashkir State Medical UniversityRussian FederationФГБОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России ; ФКУ «ЦВКГ им. П.В. Мандрыка» Минобороны РоссииРоссияPirogov Russian National Research Medical University ; Mandryka Central Clinical Military HospitalRussian FederationФГБОУ ВО «БГМУ» Минздрава РоссииРоссияBashkir State Medical UniversityRussian Federation2024190920242335466Copyright © Галимова А.Б., Куроедов А.В., Галимова В.У., 20242024Галимова А.Б., Куроедов А.В., Галимова В.У.Galimova A.B., Kuroyedov A.V., Galimova V.U.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.glaucomajournal.ru/jour/article/view/536

Взаимосвязь между глаукомой и ретинальной венозной окклюзией (РВО) является предметом неиссякаемого научного интереса. В ряде популяционных исследований глаукома выделена в качестве значимого фактора риска развития РВО. В то же время сведения о взаимосвязи между различными формами первичной глаукомы и РВО носят противоречивый характер. Уточнение характера этой взаимосвязи и выявление ее возможной патогенетической основы позволит усовершенствовать подходы к лечению этих заболеваний.

В обзоре обобщены сведения о взаимосвязи между различными формами первичной глаукомы и РВО. Установлена роль первичной открытоугольной глаукомы как фактора риска развития РВО. Обсуждено влияние локальных нарушений гемодинамики на развитие и прогрессирование первичной открытоугольной глаукомы. Отмечены различия во влиянии первичной закрытоугольной глаукомы на развитие окклюзии центральной вены сетчатки и ее ветвей. Обобщены сведения о влиянии лекарственных препаратов, применяемых для лечения макулярного отека на фоне РВО, на уровень внутриглазного давления. Даны рекомендации по выбору метода лечения макулярного отека на фоне окклюзии вен сетчатки с учетом представленных данных.

The relationship between glaucoma and retinal vein occlusion (RVO) has been a subject of ongoing scientific interest. Several population-based studies have identified glaucoma as a significant risk factor for the development of RVO. However, data on the relationship between different types of primary glaucoma and RVO remain contradictory. Clarifying the nature of this relationship and identifying its possible pathogenic basis could improve treatment approaches for these conditions.

This review summarizes information on the relationship between various types of primary glaucoma and RVO, establishes the role of primary open-angle glaucoma as a risk factor for RVO development, and discusses the impact of localized hemodynamic disturbances on the development and progression of primary open-angle glaucoma. The article also notes the different ways in which primary angle-closure glaucoma can affect the development of occlusion of central retinal vein and its branches, and summarizes the information on the influence of medications used to treat macular edema in RVO on intraocular pressure. Recommendations are provided on the selection of treatment methods for macular edema associated with retinal vein occlusion, taking into account the presented data.

первичная открытоугольная глаукомапервичная закрытоугольная глаукомаретинальная венозная окклюзияокклюзия центральной вены сетчаткианти-VEGF терапияprimary open-angle glaucomaprimary angle-closure glaucomaretinal vein occlusioncentral retinal vein occlusionanti-VEGF therapyReferencesKlein R., Moss S.E., Meuer S.M., Klein B.E. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126:513-518. https://doi.org/10.1001/archopht.126.4.513Klein R., Moss S.E., Meuer S.M., Klein B.E. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126:513-518. https://doi.org/10.1001/archopht.126.4.513Rogers S., McIntosh R.L., Cheung N., Lim L., et al. The prevalence of retinal vein occlusion: pooled data from the United States, Europe, Asia and Australia. Ophthalmology 2010; 117:313-319. https://doi.org/10.1016/j.ophtha.2009.07.017Rogers S., McIntosh R.L., Cheung N., Lim L., et al. The prevalence of retinal vein occlusion: pooled data from the United States, Europe, Asia and Australia. Ophthalmology 2010; 117:313-319. https://doi.org/10.1016/j.ophtha.2009.07.017Hayreh S.S., Zimmerman M.B., Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117:429-441. https://doi.org/10.1016/s0002-9394(14)70001-7Hayreh S.S., Zimmerman M.B., Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117:429-441. https://doi.org/10.1016/s0002-9394(14)70001-7Cheung N., Klein R., Wang J.J., Cotch M.F., et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci 2008; 49: 4297-4302. https://doi.org/10.1167/iovs.08-1826Cheung N., Klein R., Wang J.J., Cotch M.F., et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci 2008; 49: 4297-4302. https://doi.org/10.1167/iovs.08-1826Stem M.S., Talwar N., Comer G.M., Stein J.D. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2013; 120:362-370. https://doi.org/10.1016/j.ophtha.2012.07.080Stem M.S., Talwar N., Comer G.M., Stein J.D. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2013; 120:362-370. https://doi.org/10.1016/j.ophtha.2012.07.080Gaba W.H., Ahmed D., Al Nuaimi R.K., Dhanhani A.A., et al. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia. Am J Case Rep 2020; 21:e927691. https://doi.org/10.12659/AJCR.927691Gaba W.H., Ahmed D., Al Nuaimi R.K., Dhanhani A.A., et al. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia. Am J Case Rep 2020; 21:e927691. https://doi.org/10.12659/AJCR.927691Kapataeyes N., Joondeph B. Retinal vein occlusion associated with Covid-19. Retina Today 2020; 9:32-33.Kapataeyes N., Joondeph B. Retinal vein occlusion associated with Covid-19. Retina Today 2020; 9:32-33.Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and Eye: A review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021; 69(3):488-509. https://doi.org/10.4103/ijo.IJO_297_21Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and Eye: A review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021; 69(3):488-509. https://doi.org/10.4103/ijo.IJO_297_21Walinjkar J.A., Makhija S.C., Sharma H.R., Morekar S.R., et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol 2020; 68(11):2572-2574. https://doi.org/10.4103/ijo.IJO_2575_20Walinjkar J.A., Makhija S.C., Sharma H.R., Morekar S.R., et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol 2020; 68(11):2572-2574. https://doi.org/10.4103/ijo.IJO_2575_20Sheth J.U., Narayanan R., Goyal J., Goyal V. Retinal vein occlusion in COVID-19. Indian Journal of Ophthalmology 2020; 68(10):2291-2293.Sheth J.U., Narayanan R., Goyal J., Goyal V. Retinal vein occlusion in COVID-19. Indian Journal of Ophthalmology 2020; 68(10):2291-2293.Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-267. https://doi.org/10.1136/bjo.2005.081224Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-267. https://doi.org/10.1136/bjo.2005.081224Tham Y.C., Li X., Wong T.Y., Quigley H.A., et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121:2081- 2090. https://doi.org/10.1016/j.ophtha.2014.05.013Tham Y.C., Li X., Wong T.Y., Quigley H.A., et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121:2081- 2090. https://doi.org/10.1016/j.ophtha.2014.05.013Нестеров А.П. Глаукома: основные проблемы, новые возможности. Вестник офтальмологии 2008; 124 (1):3-7.Nesterov A.P. Glaucoma: basic problems, new opportunities. Vestnik Oftal’mologii 2008; 124(1):3-7.Grzybowski A., Och M., Kanclerz P., Leffler C., et al. Primary Open Angle Glaucoma and Vascular Risk Factors: A Review of Population Based Studies from 1990 to 2019. J Clin Med 2020; 9(3):761. https://doi.org/10.3390/jcm9030761.Grzybowski A., Och M., Kanclerz P., Leffler C., et al. Primary Open Angle Glaucoma and Vascular Risk Factors: A Review of Population Based Studies from 1990 to 2019. J Clin Med 2020; 9(3):761. https://doi.org/10.3390/jcm9030761.European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition – Chapter 2: Classification and terminology Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol 2017; 101(5):73-127. https://doi.org/10.1136/bjophthalmol-2016-EGSguideline.002.European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition – Chapter 2: Classification and terminology Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol 2017; 101(5):73-127. https://doi.org/10.1136/bjophthalmol-2016-EGSguideline.002.Yanagi M., Kawasaki R., Wang J.J., Wong T.Y., et al. Vascular risk factors in glaucoma: a review. Clin Exp Ophthalmol 2011; 39(3):252-258. https://doi.org/10.1111/j.1442-9071.2010.02455.x.Yanagi M., Kawasaki R., Wang J.J., Wong T.Y., et al. Vascular risk factors in glaucoma: a review. Clin Exp Ophthalmol 2011; 39(3):252-258. https://doi.org/10.1111/j.1442-9071.2010.02455.x.Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993; 116:286-296.Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993; 116:286-296.Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114:545-554.Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114:545-554.Mitchell P., Smith W., Chang A. Prevalence and association of retinal vein occlusion in Australia: The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114:1243-1247. https://doi.org/10.1001/archopht.1996.01100140443012Mitchell P., Smith W., Chang A. Prevalence and association of retinal vein occlusion in Australia: The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114:1243-1247. https://doi.org/10.1001/archopht.1996.01100140443012Cugati S., Wang J.J., Rochtchina E., Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006; 124:726-732. https://doi.org/10.1001/archopht.124.5.726Cugati S., Wang J.J., Rochtchina E., Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006; 124:726-732. https://doi.org/10.1001/archopht.124.5.726Thapa R., Paudyal G., Bernstein P.S. Demographic characteristics patterns and risk factors for retinal vein occlusion in Nepal: a hospitalbased case-control study. Clin Exp Ophthalmol 2010; 38:583-590. https://doi.org/10.1111/j.1442-9071.2010.02295.xThapa R., Paudyal G., Bernstein P.S. Demographic characteristics patterns and risk factors for retinal vein occlusion in Nepal: a hospitalbased case-control study. Clin Exp Ophthalmol 2010; 38:583-590. https://doi.org/10.1111/j.1442-9071.2010.02295.xXu K., Wu L., Ma Z., Liu Y., et al. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion. Acta Ophthalmol 2019; 97:e364-e372. https://doi.org/10.1111/aos.13879Xu K., Wu L., Ma Z., Liu Y., et al. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion. Acta Ophthalmol 2019; 97:e364-e372. https://doi.org/10.1111/aos.13879Coscas G., Loewenstein A., Augustin A., Bandello F., et al. Management of retinal vein occlusion – Consensus document. Ophthalmologica 2011; 226:4-28. https://doi.org/10.1159/000327391Coscas G., Loewenstein A., Augustin A., Bandello F., et al. Management of retinal vein occlusion – Consensus document. Ophthalmologica 2011; 226:4-28. https://doi.org/10.1159/000327391Haymore J.G., Mejico L.J. Retinal vascular occlusion syndromes. Int Ophthalmol Clin 2009; 49:63-79. https://doi.org/10.1097/IIO.0b013e3181a8db88Haymore J.G., Mejico L.J. Retinal vascular occlusion syndromes. Int Ophthalmol Clin 2009; 49:63-79. https://doi.org/10.1097/IIO.0b013e3181a8db88Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981; 79:371-422.Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981; 79:371-422.Frangieh G.T., Green W.R., Barraquer-Somers E., Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch of Ophthalmol 1982; 100(7):1132-1140. https://doi.org/10.1001/archopht.1982.01030040110020Frangieh G.T., Green W.R., Barraquer-Somers E., Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch of Ophthalmol 1982; 100(7):1132-1140. https://doi.org/10.1001/archopht.1982.01030040110020Duker J.S., Brown G.C. Anterior location of crossing artery in branch retinal vein obstruction. Arch Ophthalmol 1989; 107(7):998-1000. https://doi.org/10.1001/archopht.1989.01070020060029Duker J.S., Brown G.C. Anterior location of crossing artery in branch retinal vein obstruction. Arch Ophthalmol 1989; 107(7):998-1000. https://doi.org/10.1001/archopht.1989.01070020060029Christoffersen N.L., Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999; 106(11):2054- 2062. https://doi.org/10.1016/S0161-6420(99)90483-9Christoffersen N.L., Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999; 106(11):2054- 2062. https://doi.org/10.1016/S0161-6420(99)90483-9Paszkowiak J.J., Dardik A. Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg 2003; 37(1): 47-57. https://doi.org/10.1177/153857440303700107Paszkowiak J.J., Dardik A. Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg 2003; 37(1): 47-57. https://doi.org/10.1177/153857440303700107Haymore J.G., Mejico L.J. Retinal vascular occlusion syndromes. Int Ophthalmol Clin 2009; 49:63-79. https://doi.org/10.1097/IIO.0b013e3181a8db88Haymore J.G., Mejico L.J. Retinal vascular occlusion syndromes. Int Ophthalmol Clin 2009; 49:63-79. https://doi.org/10.1097/IIO.0b013e3181a8db88Кански Д. Клиническая офтальмология: систематизированный подход. 2-е изд., под ред. В.П. Еричева. Wroclaw: Elsevier Urban& Partner 2009; 944.Kanski J. Clinical ophthalmology: a systematic approach. 2nd ed. Elsevier Urban&Partner, 2009. 944 p.Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., et al. Leukocytemediated endothelial cell injury and death in diabetic retina. Am J Pathol 2001; 158:147-152. https://doi.org/10.1016/S0002-9440(10)63952-1Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., et al. Leukocytemediated endothelial cell injury and death in diabetic retina. Am J Pathol 2001; 158:147-152. https://doi.org/10.1016/S0002-9440(10)63952-1Тульцева С.Н., Астахов Ю.С. Роль воспаления в патогенезе посттромботического макулярного отека. Современные направления медикаментозного лечения. Офтальмологические ведомости 2012; 1(4):35-44.Tultseva S.N., Astakhov Yu.S. The role of inflammation in the pathogenesis of macular edema. Modern trends of medical treatment. Oftalmologičeskie vedomosti 2012; 1(4):35-44.Daurich A., Matet A., Moulin A., Kowalzcuk L., et al. Mechanisms of macular edema: Beyond the surface. Progress in Retinal and Eye Research 2018; 63:20-68. https://doi.org/10.1016/j.preteyeres.2017.10.006.Daurich A., Matet A., Moulin A., Kowalzcuk L., et al. Mechanisms of macular edema: Beyond the surface. Progress in Retinal and Eye Research 2018; 63:20-68. https://doi.org/10.1016/j.preteyeres.2017.10.006.Yin X., Li L., Zhang B., Lu P. Association of glaucoma with risk of re-tinal vein occlusion: a meta-analysis. Acta Ophthalmol 2019; 97:652-659. https://doi.org/10.1111/aos.1414.Yin X., Li L., Zhang B., Lu P. Association of glaucoma with risk of re-tinal vein occlusion: a meta-analysis. Acta Ophthalmol 2019; 97:652-659. https://doi.org/10.1111/aos.1414.Klein R., Klein B.E., Moss S.E., Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98:133-141.Klein R., Klein B.E., Moss S.E., Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98:133-141.Hirota A., Mishima H.K., Kiuchi Y. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997; 211(5):288-291. https://doi.org/10.1159/000310810.Hirota A., Mishima H.K., Kiuchi Y. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997; 211(5):288-291. https://doi.org/10.1159/000310810.Liu W., Xu L., Jonas J.B. Vein occlusion in Chinese subjects. Ophthalmology 2007; 114:1795-1796. https://doi.org/10.1016/j.ophtha.2007.03.010Liu W., Xu L., Jonas J.B. Vein occlusion in Chinese subjects. Ophthalmology 2007; 114:1795-1796. https://doi.org/10.1016/j.ophtha.2007.03.010Barnett E.M., Fantin A., Wilson B.S., Kass M.A., et al. Ocular Hypertension Treatment Study Group. The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology 2010; 117(3):484-488. https://doi.org/10.1016/j.ophtha.2009.08.022Barnett E.M., Fantin A., Wilson B.S., Kass M.A., et al. Ocular Hypertension Treatment Study Group. The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology 2010; 117(3):484-488. https://doi.org/10.1016/j.ophtha.2009.08.022Wittström E., Ponjavic V., Lövestam-Adrian M., Larsson J., et al. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Acta Ophthalmol 2010; 88:86-90. https://doi.org/10.1111/j.1755-3768.2008.01424.xWittström E., Ponjavic V., Lövestam-Adrian M., Larsson J., et al. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Acta Ophthalmol 2010; 88:86-90. https://doi.org/10.1111/j.1755-3768.2008.01424.xFrucht J., Shapiro A., Merin S. Intraocular pressure in retinal vein occlusion. Br J Ophthalmol 1984; 68:26-28.Frucht J., Shapiro A., Merin S. Intraocular pressure in retinal vein occlusion. Br J Ophthalmol 1984; 68:26-28.Klein B.E., Meuer S.M., Knudtson M.D., Klein R. The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol. 2006; 141:859-862. https://doi.org/10.1016/j.ajo.2005.12.015Klein B.E., Meuer S.M., Knudtson M.D., Klein R. The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol. 2006; 141:859-862. https://doi.org/10.1016/j.ajo.2005.12.015Beaumont P.E., Kang H.K. Cup-to-disk ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion. Ophthalmology 2002; 109:282-286. https://doi.org/10.1016/s0161-6420(01)00922-8Beaumont P.E., Kang H.K. Cup-to-disk ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion. Ophthalmology 2002; 109:282-286. https://doi.org/10.1016/s0161-6420(01)00922-8Jonas J.B., Berenshtein E., Holbach L. Anatomic relationship between lamina cribrosa, intraocular space and cerebrospinal fluid space. Invest Ophthalmol Vis Sci 2003; 44:5189-5195. https://doi.org/10.1167/iovs.03-0174Jonas J.B., Berenshtein E., Holbach L. Anatomic relationship between lamina cribrosa, intraocular space and cerebrospinal fluid space. Invest Ophthalmol Vis Sci 2003; 44:5189-5195. https://doi.org/10.1167/iovs.03-0174Sin B.H., Song B.J., Park S.P. Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma. J Glaucoma 2013; 22(2):104-109. https://doi.org/10.1097/IJG.0b013e3182312047.Sin B.H., Song B.J., Park S.P. Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma. J Glaucoma 2013; 22(2):104-109. https://doi.org/10.1097/IJG.0b013e3182312047.Park H-Y., Jeong H.J., Kim Y.H., Park C.K. Optic disc hemorrhage is related to various hemodynamic findings by disc angiography. PLoS One 2015; 10: e0120000. https://doi.org/10.1371/journal.pone.0120000.Park H-Y., Jeong H.J., Kim Y.H., Park C.K. Optic disc hemorrhage is related to various hemodynamic findings by disc angiography. PLoS One 2015; 10: e0120000. https://doi.org/10.1371/journal.pone.0120000.Baek J., Jeon S.J., Kim J.H., Park C.K., et al. Optic Disc Vascular Density in Normal-Tension Glaucoma Eyes with or without Branch Retinal Vessel Occlusion. J Clin Med 2021; 10(12):2574. https://doi.org/10.3390/jcm10122574.Baek J., Jeon S.J., Kim J.H., Park C.K., et al. Optic Disc Vascular Density in Normal-Tension Glaucoma Eyes with or without Branch Retinal Vessel Occlusion. J Clin Med 2021; 10(12):2574. https://doi.org/10.3390/jcm10122574.Na K.I., Jeoung J.W., Kim Y.K., Lee W.J., et al. Incidence of Open-angle Glaucoma in Newly Diagnosed Retinal Vein Occlusion: A Nationwide Population-based Study. J Glaucoma 2019; 28(2):111-118. https://doi.org/10.1097/IJG.0000000000001134Na K.I., Jeoung J.W., Kim Y.K., Lee W.J., et al. Incidence of Open-angle Glaucoma in Newly Diagnosed Retinal Vein Occlusion: A Nationwide Population-based Study. J Glaucoma 2019; 28(2):111-118. https://doi.org/10.1097/IJG.0000000000001134Park H-Y., Jung Y., Han K., Lee M.Y., et al. Health care claims for primary open-angle glaucoma and retinal vein occlusion from an 11-year nationwide dataset. Scientific reports 2017; 7:8038. https://doi.org/10.1038/s41598-017-07890-6.Park H-Y., Jung Y., Han K., Lee M.Y., et al. Health care claims for primary open-angle glaucoma and retinal vein occlusion from an 11-year nationwide dataset. Scientific reports 2017; 7:8038. https://doi.org/10.1038/s41598-017-07890-6.Park H-Y., Jeon S., Lee M.Y., Park C.K. Glaucoma progression in the unaffected fellow eye of glaucoma patients who developed unilateral branch retinal vein occlusion. Am J Ophthalmol 2017; 175:194-200. https://doi.org/10.1016/j.ajo.2016.10.009.Park H-Y., Jeon S., Lee M.Y., Park C.K. Glaucoma progression in the unaffected fellow eye of glaucoma patients who developed unilateral branch retinal vein occlusion. Am J Ophthalmol 2017; 175:194-200. https://doi.org/10.1016/j.ajo.2016.10.009.Shin Y.I., Nam K.Y., Lee S.E., Lim H-B., et al. Changes in Peripapillary Microvasculature and Retinal Thickness in the Fellow Eyes of Patients With Unilateral Retinal Vein Occlusion: An OCTA Study. Invest Ophthalmol Vis Sci 2019; 60(2):823-829. https://doi.org/10.1167/iovs.18-26288.Shin Y.I., Nam K.Y., Lee S.E., Lim H-B., et al. Changes in Peripapillary Microvasculature and Retinal Thickness in the Fellow Eyes of Patients With Unilateral Retinal Vein Occlusion: An OCTA Study. Invest Ophthalmol Vis Sci 2019; 60(2):823-829. https://doi.org/10.1167/iovs.18-26288.Fan L., Zhu Y., Sun X., Yu J., et al. Patients with unilateral retinal vein occlusion show reduced radial peripapillary capillary density in their fellow eyes. BMC Ophthalmol 2021; 21:448-456. https://doi.org/10.1186/s12886-021-02192-y.Fan L., Zhu Y., Sun X., Yu J., et al. Patients with unilateral retinal vein occlusion show reduced radial peripapillary capillary density in their fellow eyes. BMC Ophthalmol 2021; 21:448-456. https://doi.org/10.1186/s12886-021-02192-y.Wang X., Jiang C., Ko T., Kong X., et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol 2015; 253(9):1557-1564. https://doi.org/10.1007/s00417-015-3095-y.Wang X., Jiang C., Ko T., Kong X., et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol 2015; 253(9):1557-1564. https://doi.org/10.1007/s00417-015-3095-y.Курышева Н.И., Маслова Е.В., Трубилина А.В. Снижение перипапиллярного кровотока как фактор развития и прогрессирования первичной открытоугольной глаукомы. Российский офтальмологический журнал 2016; 3:34-41. https://doi.org/10.21516/2072-0076-2016-9-3-34-41.Kurysheva N.I., Maslova E.V., Trubilina A.V. A reduced peripapillary blood flow as a factor of primary open angle glaucoma development and progression. Russian Ophthalmological Journal 2016; 3:34-41. https://doi.org/10.21516/2072-0076-2016-9-3-34-41.Юрьева Т.Н., Жукова С.И. ОКТ-ангиография в комплексной оценке эффективности гипотензивной терапии у больных с первичной открытоугольной глаукомой. Российский офтальмологический журнал 2019; 12(3):43-49. https://doi.org/10.21516/2072-0076-2019-12-3-43-49.Yurieva T.N., Zhukova S.I. OCT-angiography in a comprehensive assessment of the hypotensive therapy effectiveness in patients with primary open-angle glaucoma. Russian Ophthalmological Journal 2019; 12(3):43-49. https://doi.org/10.21516/2072-0076-2019-12-3-43-49Курышева Н.И. ОКТ-ангиография и ее роль в исследовании ретинальной микроциркуляции при глаукоме (часть вторая). Российский офтальмологический журнал 2018; 11(3):95-100. https://doi.org/10.21516/2072-0076-2018-11-3-95-100.Kurysheva N.I. OCT angiography and its role in the study of retinal microcirculation in glaucoma (part two). Russian ophthalmological journal 2018; 11(3):95–100. https://doi.org/10.21516/2072-0076-2018-11-3-95-100.Rao H.L., Pradhan Z.S., Weinreb RN., Reddy H.B., et al. Regional comparisons of optical coherence tomography angiography vessel density in primary open-angle glaucoma. Am J Ophthalmol 2016; 171:75-83. https://doi.org/10.1016/j.ajo.2016.08.030.Rao H.L., Pradhan Z.S., Weinreb RN., Reddy H.B., et al. Regional comparisons of optical coherence tomography angiography vessel density in primary open-angle glaucoma. Am J Ophthalmol 2016; 171:75-83. https://doi.org/10.1016/j.ajo.2016.08.030.Kurysheva N.I. Macula in glaucoma: vascularity evaluated by OCT angiography. Res J Pharmaceutical, Biological and Chemical Sci 2016; 7(5):651-662.Kurysheva N.I. Macula in glaucoma: vascularity evaluated by OCT angiography. Res J Pharmaceutical, Biological and Chemical Sci 2016; 7(5):651-662.Michaelides M., Foster P.J. Retinal vein occlusion and angle closure: a retrospective case series. J Glaucoma 2010; 19:643-649. https://doi.org/10.1097/IJG.0b013e3181d12deaMichaelides M., Foster P.J. Retinal vein occlusion and angle closure: a retrospective case series. J Glaucoma 2010; 19:643-649. https://doi.org/10.1097/IJG.0b013e3181d12deaMohammadi M., Bazvand F., Makateb A., Eslami Y., et al. Comparison of anterior segment optical coherence tomography parameters between central retinal vein occlusion and normal eyes: is primary angle closure a risk factor for central retinal vein occlusion? Retina 2015; 35(9):1795-1799. https://doi.org/10.1097/IAE.0000000000000549.Mohammadi M., Bazvand F., Makateb A., Eslami Y., et al. Comparison of anterior segment optical coherence tomography parameters between central retinal vein occlusion and normal eyes: is primary angle closure a risk factor for central retinal vein occlusion? Retina 2015; 35(9):1795-1799. https://doi.org/10.1097/IAE.0000000000000549.Wu S.C., Lee Y.S., Wu W.C., Chang S.H. Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion. BMC Ophthalmol 2016; 16:68. https://doi.org/10.1186/s12886-016-0256-7Wu S.C., Lee Y.S., Wu W.C., Chang S.H. Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion. BMC Ophthalmol 2016; 16:68. https://doi.org/10.1186/s12886-016-0256-7Cheng C.S., Lee Y.F., Ong C., Yap Z.L., et al. Intereye comparison of retinal oximetry and vessel caliber between eyes with asymmetrical glaucoma severity in different glaucoma subtypes. Clin Ophthalmol 2016; 10:1315-1321. https://doi.org/10.2147/OPTH.S96529.Cheng C.S., Lee Y.F., Ong C., Yap Z.L., et al. Intereye comparison of retinal oximetry and vessel caliber between eyes with asymmetrical glaucoma severity in different glaucoma subtypes. Clin Ophthalmol 2016; 10:1315-1321. https://doi.org/10.2147/OPTH.S96529.Jonas J.B., Nangia V., Khare A., Sinha A., et al. Prevalence and associations of retinal vein occlusions: the Central India Eye and Medical Study. Retina 2013; 33:152-159. https://doi.org/10.1097/IAE.0b013e318260246f.Jonas J.B., Nangia V., Khare A., Sinha A., et al. Prevalence and associations of retinal vein occlusions: the Central India Eye and Medical Study. Retina 2013; 33:152-159. https://doi.org/10.1097/IAE.0b013e318260246f.Călugăru D, Călugăru M. Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions. Int J Ophthalmol 2021; 14(6):931-935. https://doi.org/10.18240/ijo.2021.06.20.Călugăru D, Călugăru M. Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions. Int J Ophthalmol 2021; 14(6):931-935. https://doi.org/10.18240/ijo.2021.06.20Feltgen N., Junker B., Agostini H., Hansen L.L. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007; 114:716-723. https://doi.org/10.1016/j.ophtha.2006.06.064.Feltgen N., Junker B., Agostini H., Hansen L.L. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007; 114:716-723. https://doi.org/10.1016/j.ophtha.2006.06.064.Тульцева С.Н. Использование рекомбинантного тканевого активатора плазминогена в лечении окклюзий вен сетчатки. Офтальмологические ведомости 2010; 3(1):42-50.Tultseva S.N. The use of recombinant tissue plasminogen activator in treatment of retinal vein occlusions. Oftalmologičeskie vedomosti. 2010; 3(1):42-50.Fekrat S., de Juan E Jr. Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture. Ophthalmic Surg Lasers 1999; 30:52-55.Fekrat S., de Juan E Jr. Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture. Ophthalmic Surg Lasers 1999; 30:52-55.McAllister I.L., Gillies M.E., Smithies L.A., Rochtchina E., et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology 2010; 117:954-965. https://doi.org/10.1016/j.ophtha.2009.10.026.McAllister I.L., Gillies M.E., Smithies L.A., Rochtchina E., et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology 2010; 117:954-965. https://doi.org/10.1016/j.ophtha.2009.10.026.Arevalo J.F., Garcia R.A., Wu L., Rodriguez F.J., et al. Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina 2008; 28:1044- 1052. https://doi.org/10.1097/IAE.0b013e3181744153.Arevalo J.F., Garcia R.A., Wu L., Rodriguez F.J., et al. Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina 2008; 28:1044- 1052. https://doi.org/10.1097/IAE.0b013e3181744153.Opremcak E.M., Bruce R.A. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999; 19(1):1-5. https://doi.org/10.1097/00006982-199901000-00001Opremcak E.M., Bruce R.A. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999; 19(1):1-5. https://doi.org/10.1097/00006982-199901000-00001Campochiaro P.A., Hafiz G., Shah S.M., Nguen Q.D., et al. Ranibizumab for macular edema due to retinal vein occlusions: Impication of VEGF as a critical stimulator. Mol Ther 2008; 16:791-799. https://doi.org/10.1038/mt.2008.10Campochiaro P.A., Hafiz G., Shah S.M., Nguen Q.D., et al. Ranibizumab for macular edema due to retinal vein occlusions: Impication of VEGF as a critical stimulator. Mol Ther 2008; 16:791-799. https://doi.org/10.1038/mt.2008.10Campochiaro P.A., Brown D.M., Awh C.C., Lee S.Y., et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011; 118:2041-2049. https://doi.org/10.1016/j.ophtha.2011.02.038.Campochiaro P.A., Brown D.M., Awh C.C., Lee S.Y., et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011; 118:2041-2049. https://doi.org/10.1016/j.ophtha.2011.02.038.Pielen A., Clark W.L., Boyer D.S., Ogura Y., et al. Integrated results from the COPERNICUS and GALILEO studies. Clin Ophthalmol 2017; 11:1533-1540. https://doi.org/10.2147/OPTH.S140665Pielen A., Clark W.L., Boyer D.S., Ogura Y., et al. Integrated results from the COPERNICUS and GALILEO studies. Clin Ophthalmol 2017; 11:1533-1540. https://doi.org/10.2147/OPTH.S140665Campochiaro PA, Sophie R, Pearlman J, Brown DM, et al.; RETAIN Study Group. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN Study. Ophthalmology 2014; 119(4):802-809. https://doi.org/10.1016/j.ophtha.2013.08.038.Campochiaro PA, Sophie R, Pearlman J, Brown DM, et al.; RETAIN Study Group. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN Study. Ophthalmology 2014; 119(4):802-809. https://doi.org/10.1016/j.ophtha.2013.08.038.Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Луцентис ЛСР-004567/08 от 2021 г. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=3fd02ed3-e9fc-4835-97a4-56d19b69227c&t=.State Register of Medicines. Instruction for medical use of Lucentis LSR-004567/08 from 2021. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=3fd02ed3-e9fc-4835-97a4-56d19b69227c&t=.Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Эйлеа ЛП-003544 от 2020 г. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9e73411f-469d-4c90-a305-0bb1ec0aefdc&t=.State Register of Medicines. Instruction for medical use of Eyelea LP-003544 from 2020 [In Russian]. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9e73411f-469d-4c90-a305-0bb1ec0aefdc&t=.de Vries V.A., Bassil F.L., Ramdas W.D. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep 2020; 10:132-148. https://doi.org/10.1038/s41598-020-70269-7.de Vries V.A., Bassil F.L., Ramdas W.D. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep 2020; 10:132-148. https://doi.org/10.1038/s41598-020-70269-7.Noma H., Funatsu H., Mimura T., Eguchi S. Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case-control series. J Inflamm (Lond) 2011; 8:38. https://doi.org/10.1186/1476-9255-8-38.Noma H., Funatsu H., Mimura T., Eguchi S. Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case-control series. J Inflamm (Lond) 2011; 8:38. https://doi.org/10.1186/1476-9255-8-38.Тульцева С.Н., Астахов Ю.С. Роль воспаления в патогенезе посттромботического макулярного отека. Современные направления медикаментозного лечения. Офтальмологические ведомости 2012; 1(4):35-44.Tultseva S.N., Astakhov S.Yu. The role of inflammation in the pathogenesis of macular edema. Modern trends of medical treatment. Oftalmologičeskie vedomosti 2012; 1(4):35-44.Тульцева С.Н., Астахов Ю.С., Нечипоренко П.А., Овнанян А.Ю. и др. Ранибизумаб и лазерная коагуляция сетчатки в терапии ишемической окклюзии ретинальных вен. Офтальмологические ведомости 2015; 8(2):11-27. https://doi.org/10.17816/OV2015211-27.Tultseva S.N., Astakhov S.Yu., Nechiporenko P.A., Ovnanyan A.Yu. Ranibizumab and retinal photocoagulation in the treatment of ischemic retinal vein occlusion. Oftalmologičeskie vedomosti 2015; 8(2): 11-27. https://doi.org/10.17816/OV2015211-27.Дроздова Е.А., Хохлова Д.Ю., Мезенцева Е.А., Никушкина К.В. Исследование системного и локального уровня цитокинов при окклюзии вен сетчатки на фоне антиангиогенной терапии. Медицинская иммунология 2018; 20(3):365-372. https://doi.org/10.15789/1563-0625-2018-3-365-372.Drozdova E.A., Khokhlova D.Yu., Mezentseva E.A., Nikushkina K.V. studies of systemic and local cytokine level in retinal vein occlusion associated with antiangiogenic therapy. Medical Immunology 2018; 20(3):365-372. https://doi.org/10.15789/1563-0625-2018-3-365-372.Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Озурдекс ЛП-001913 от 2018 г. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9b03a91d-5af5-40e3-8ede-861465217c81.State Register of Medicines. Instruction for medical use of Ozurdex LP-001913 from 2018. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9b03a91d-5af5-40e3-8ede-861465217c81.Haller J.A., Bandello F., Belfort R. Jr., Blumenkranz M.S., et al. OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117(6):1134- 1146.e3. https://doi.org/10.1016/j.ophtha.2010.03.032.Haller J.A., Bandello F., Belfort R. Jr., Blumenkranz M.S., et al. OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117(6):1134- 1146.e3. https://doi.org/10.1016/j.ophtha.2010.03.032.Capone A. Jr., Singer M.A., Dodwell D.G., Dreyer R.F., et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study). Retina 2014; 34(2):342-351. https://doi.org/10.1097/IAE.0b013e318297f842.Capone A. Jr., Singer M.A., Dodwell D.G., Dreyer R.F., et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study). Retina 2014; 34(2):342-351. https://doi.org/10.1097/IAE.0b013e318297f842.Querques L., Querques G., Lattanzio R., Gigante S.R., et al. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica 2013; 229(1):21-25. https://doi.org/10.1159/000342160.Querques L., Querques G., Lattanzio R., Gigante S.R., et al. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica 2013; 229(1):21-25. https://doi.org/10.1159/000342160.Hemarat K., Kemmer J.D., Porco T.C., Eaton A.M., et al. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice. Ophthalmic Surg Lasers Imaging Retina 2018; 49:680-685. https://doi.org/10.3928/23258160-20180831-05.Hemarat K., Kemmer J.D., Porco T.C., Eaton A.M., et al. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice. Ophthalmic Surg Lasers Imaging Retina 2018; 49:680-685. https://doi.org/10.3928/23258160-20180831-05.Malclès A, Dot C, Voirin N, Viè A-L., et al. Safety of intravitreal dexamethasone implant (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension. Retina 2017; 37:1352-1359. https://doi.org/10.1097/IAE.0000000000001369.Malclès A, Dot C, Voirin N, Viè A-L., et al. Safety of intravitreal dexamethasone implant (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension. Retina 2017; 37:1352-1359. https://doi.org/10.1097/IAE.0000000000001369.Hattenbach L.O., Feltgen N., Bertelmann T., Schmitz-Valckenberg S., et al. COMRADE-B Study Group. Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B). Acta Ophthalmol 2018; 96(1):e10-e18. https://doi.org/10.1111/aos.13381.Hattenbach L.O., Feltgen N., Bertelmann T., Schmitz-Valckenberg S., et al. COMRADE-B Study Group. Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B). Acta Ophthalmol 2018; 96(1):e10-e18. https://doi.org/10.1111/aos.13381.Feltgen N., Hattenbach L.O., Bertelmann T., Callizo J., et al. Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. Acta Ophthalmol 2018; 96:e933-e941. https://doi.org/10.1111/aos.13770.Feltgen N., Hattenbach L.O., Bertelmann T., Callizo J., et al. Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. Acta Ophthalmol 2018; 96:e933-e941. https://doi.org/10.1111/aos.13770.Erfurth-Schmidt U., Garcia-Arumi J., Gerendas B.S., Midena E., et al. Guidelines for the management of retinal vein occlusion by the European Society of retina specialists (EURETINA). Ophthalmologica 2019; 242(3):123-162. https://doi.org/10.1159/000502041.Erfurth-Schmidt U., Garcia-Arumi J., Gerendas B.S., Midena E., et al. Guidelines for the management of retinal vein occlusion by the European Society of retina specialists (EURETINA). Ophthalmologica 2019; 242(3):123-162. https://doi.org/10.1159/000502041.

The authors declare that there are no conflicts of interest present.